Soluble CD23 expression as a marker of immunomodulation and clinical response in asthma patients treated with omalizumab
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 26 Nov 2005 New trial record.